Emergencies preparedness, response

International Coordinating Group (ICG) on vaccine provision for cholera

The WHO vaccination team had to implement strategic measures in Iraq to cover the whole population. Vaccination was performed at markets in the vicinity of targeted camps to cover working men.
WHO/R. Lopes

The ICG manages the global stockpile of oral cholera vaccine which was created as an additional tool to help control cholera epidemics. Since July 2013, the ICG has released more than 5 million doses of oral cholera vaccines to affected countries.

The ICG also works with partners and stakeholders to place vaccine in the context of an integrated cholera response based around early detection, case management, provision of safe water, sanitation, and raising awareness among the affected communities.


In addition to the four members (MSF, IFRC, UNICEF and WHO), additional expertise and technical advice is provided on a case-by-case basis from a range of partners.

Accessing ICG vaccine stocks

The main objective of the oral cholera vaccine stockpile is to ensure the timely and targeted deployment of vaccine as part of an effective outbreak response. While vaccines provide a short-term effect as an immediate intervention to a potential cholera outbreak, expanding access to improved drinking-water sources and sanitation is a longer term solution for most waterborne diseases, including cholera.

To request access to ICG stocks, national or international health authorities should submit an application form to the ICG Secretariat (WHO Geneva), or to an ICG member agency (IRFC, MSF, UNICEF) present in the country. Requests are evaluated through a rapid consultation process taking into account the epidemiological situation, vaccination strategy, pre-existing stocks in the country and operational aspects of the epidemic response. Countries are informed of an ICG decision within 48 hours.

ICG cholera dashboard

Designed to record essential information on cholera vaccines requested and doses delivered through ICG.